(Isstories Editorial):- Saint Charles, Illinois Nov 15, 2023 (Issuewire.com) – Recent investigations reported by Morningstar and the New York Post have unveiled alarming lapses in safety and quality control at a pharmaceutical manufacturing facility in India. The Coalition for North American Drug Supply is calling for immediate action to address the issue and advocating for the relocation of drug production to the United States and Canada.
Key Points:
- Ensuring Safety and Quality: Recent incidents underscore the potential risks associated with overseas drug production. The Coalition advocates for localizing drug manufacturing to uphold the highest safety and quality standards.
- Protecting Public Health: Reports from both Morningstar and the New York Post highlight serious safety and quality concerns related to contaminated eye drops found at major retailers. The Coalition stresses the urgency of addressing these issues to safeguard public health.
- Barefoot Workers and Faked Safety Checks: The New York Post’s report brings attention to the shocking revelation of workers in India going barefoot during drug manufacturing and falsifying safety checks. Such practices raise significant doubts about the integrity of the global pharmaceutical supply chain.
- Immediate Action Required: The Coalition urges immediate action to address the contamination issue and investigate the conditions under which these drugs were manufactured. The health and safety of consumers are of paramount importance.
- Supply Chain Vulnerabilities: The recent incidents highlight the vulnerability of the global pharmaceutical supply chain. Localizing drug production in North America is crucial to mitigating such risks and ensuring the integrity of medicines.
- Transparent Oversight: The Coalition calls for increased transparency and oversight in the pharmaceutical industry. We believe that transparency is vital for building trust among consumers and stakeholders.
- Creating Jobs: Bringing drug production back to North America will contribute to the growth of local economies by generating employment opportunities and supporting skilled workers in the pharmaceutical industry.
- Enhancing Regulatory Oversight: In response to these revelations, the Coalition urges immediate regulatory reforms to ensure transparency, oversight, and continuous monitoring of pharmaceutical manufacturing processes.
- Collaboration Across Borders: The Coalition encourages collaboration between the United States and Canada to develop a comprehensive strategy for localizing drug production and safeguarding the health of North American citizens.
The Coalition for North American Drug Supply remains steadfast in its commitment to advocating for a secure and reliable drug supply chain. By bringing drug production back to North America, we aim to protect public health, create jobs, and ensure the highest standards of safety and quality.
More on Isstories:
- Singapore’s Wefaa Robotics receives seed funding to further transform STEAM education with its transformer robots
- Homes in America Now More Stylish – Meet Seus Lighting’s Black Chandeliers
- Cesar Quintana, DC: Building a Strong and Healthy Community Through Chiropractic Care
- CM Club Hits the Beach in Style with Its New Golden Beach Collection: Luxe Tops Proudly Made in the USA
- Antoinette “Red Lotus Chic”Apolon, Recognized by BestAgents.us as a 2024 Top Agent
For media inquiries, please contact:
Mr. Samay Verma
President
646-780-9916
